J. Gordon

2 papers in the library · publishing 2021-2023

Papers

Sort Most recent Most cited

Psychedelics as Therapeutics-Potential and Challenges.

JAMA Psychiatry July 26, 2023 Nora D. Volkow, J. Gordon, Eric M. Wargo

This Viewpoint discusses the potential promise of the therapeutic use of psychedelics for mental illness and substance use disorders, acknowledging many open research questions and unique challenges with these substances.

DOI: 10.1001/jamapsychiatry.2023.1968

Endocrine and psychosocial moderators of mindfulness-based stress reduction for the prevention of perimenopausal depressive symptoms: A randomized controlled trial.

Psychoneuroendocrinology May 19, 2021 J. Gordon, M. Halleran, Shadi Beshai et al.

BACKGROUND The menopause transition is associated with an increased risk of depressive symptoms. The current study aimed to test whether Mindfulness-Based Stress Reduction, an 8-week group intervention involving meditation and yoga, might reduce the risk of depressive symptoms among perimenopausal women. A secondary aim was to examine baseline characteristics, including sensitivity to estradiol...

DOI: 10.1016/j.psyneuen.2021.105277